scholarly article | Q13442814 |
P50 | author | Carlos Blanco | Q56089029 |
P2093 | author name string | C W Lejuez | |
Derek R Hopko | |||
Stephanie M Gorka | |||
Laura MacPherson | |||
Stacey B Daughters | |||
Jessica F Magidson | |||
P2860 | cites work | A component analysis of cognitive-behavioral treatment for depression | Q28293596 |
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. | Q34132596 | ||
Comorbid alcoholism and depression: treatment issues | Q34390028 | ||
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients | Q34413083 | ||
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions | Q34456676 | ||
Behavioral activation treatments of depression: a meta-analysis | Q34593780 | ||
Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). | Q34756974 | ||
Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment | Q35220257 | ||
Clinical implications of reinforcement as a determinant of substance use disorders | Q35639040 | ||
Racial disparities in completion rates from publicly funded alcohol treatment: economic resources explain more than demographics and addiction severity. | Q35955543 | ||
Treatment of depression in patients with opiate dependence | Q35958321 | ||
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. | Q36071603 | ||
A meta-analysis of randomized trials of behavioural treatment of depression | Q36954714 | ||
Behavioral activation is an evidence-based treatment for depression | Q37637459 | ||
A critical review of assessment strategies to measure the behavioral activation model of depression. | Q37742851 | ||
Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancers | Q40188385 | ||
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial | Q40515923 | ||
Help-seeking by substance abusers: the role of harm reduction and behavioral-economic approaches to facilitate treatment entry and retention | Q41551091 | ||
Effects of major depression on remission and relapse of substance dependence | Q43942696 | ||
Impact of alcohol detoxification on anxiety and depressive symptoms | Q44138257 | ||
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study | Q44139859 | ||
Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions | Q44334304 | ||
Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients | Q44448292 | ||
Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). | Q44689724 | ||
Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders | Q45142222 | ||
Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders. | Q45998620 | ||
Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. | Q46002698 | ||
Trends in acute mental health care: comparing psychiatric and substance abuse treatment programs | Q47957359 | ||
Policies and services in residential substance abuse programs: Comparisons with psychiatric programs | Q50116169 | ||
Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory. | Q50536722 | ||
U.S. spending for mental health and substance abuse treatment, 1991-2001. | Q50759144 | ||
The Environmental Reward Observation Scale (EROS): development, validity, and reliability. | Q50900913 | ||
The effect of depression on return to drinking: a prospective study. | Q50901534 | ||
I. Synchrony and desynchrony in fear and avoidance. | Q51303007 | ||
Do substance abuse patients with more psychopathology receive more treatment? | Q51657208 | ||
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. | Q51701712 | ||
What drove private health insurance spending on mental health and substance abuse care, 1992-1999? | Q51951136 | ||
Behavioral economic approaches to reduce college student drinking. | Q51982091 | ||
Long-term changes in current psychiatric diagnoses of treated opiate addicts. | Q52077778 | ||
Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. | Q52917210 | ||
Intent-to-treat analysis for longitudinal studies with drop-outs. | Q53215415 | ||
Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium | Q60144306 | ||
Is cognitive behavior therapy just a ‘nonspecific’ intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo | Q60620293 | ||
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study | Q69563617 | ||
Behavior therapy for drug abuse: a controlled treatment outcome study | Q72890063 | ||
The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysis | Q73526356 | ||
A brief behavioral activation treatment for depression. Treatment manual | Q73795561 | ||
Depressive symptoms among African American women with HIV disease | Q73966438 | ||
Depression as measured by the Beck Depression Inventory-II among injecting drug users | Q83283226 | ||
P433 | issue | 6 | |
P921 | main subject | substance abuse | Q3184856 |
P304 | page(s) | 615-623 | |
P577 | publication date | 2011-01-21 | |
P1433 | published in | Addictive Behaviors | Q15751369 |
P1476 | title | Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention | |
P478 | volume | 36 |
Q48079993 | A learning theory account of depression |
Q38820950 | Activity enjoyment, not frequency, is associated with alcohol-related problems and heavy episodic drinking |
Q37130498 | Adaptation of community health worker-delivered behavioral activation for torture survivors in Kurdistan, Iraq |
Q89467165 | Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City |
Q61799654 | An evaluation of the maintenance to abstinence (MTA) program in achieving abstinence in opioid users and improving mental health and quality of life |
Q93207320 | Applying behavioral economic theory to problematic Internet use: An initial investigation |
Q38919605 | Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches |
Q88562833 | Development and Preliminary Feasibility Study of a Brief Behavioral Activation Mobile Application (Behavioral Apptivation) to Be Used in Conjunction With Ongoing Therapy |
Q57147011 | Effects of behavioural activation on substance use and depression: a systematic review |
Q34549301 | Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center |
Q46154621 | Integrating Motivational Interviewing and Brief Behavioral Activation Therapy: Theoretical and Practical Considerations |
Q33922554 | Integration of the brief behavioral activation treatment for depression (BATD) into a college orientation program: depression and alcohol outcomes |
Q47405368 | Making the hard work of recovery more attractive for those with substance use disorders |
Q41395800 | Moodivate: A self-help behavioral activation mobile app for utilization in primary care-Development and clinical considerations |
Q35703179 | Motivation and Self-Regulation in Addiction: A Call for Convergence |
Q38043440 | Numbing and dysphoria symptoms of posttraumatic stress disorder among Iraq and Afghanistan War veterans: a review of findings and implications for treatment |
Q86372592 | Pilot of a Behavioral Activation-Enhanced Smoking Cessation Program for Substance Users With Elevated Depressive Symptoms in Residential Treatment |
Q33921702 | Pilot of the brief behavioral activation treatment for depression in latinos with limited english proficiency: preliminary evaluation of efficacy and acceptability |
Q46314082 | The effect of a behavioral activation treatment for substance use on post-treatment abstinence: a randomized controlled trial. |
Q33818354 | The efficacy of a behavioral activation intervention among depressed US Latinos with limited English language proficiency: study protocol for a randomized controlled trial |
Q37033880 | The efficacy of behavioral activation treatment among depressed Spanish-speaking Latinos |
Q27310906 | The efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): a randomized controlled trial |
Q40457261 | Theory-driven intervention for changing personality: expectancy value theory, behavioral activation, and conscientiousness. |
Q54945627 | Therapist tips for the brief behavioural activation therapy for depression - revised (BATD-R) treatment manual practical wisdom and clinical nuance. |
Q37939720 | Treatment failure in behavior therapy: focus on behavioral activation for depression |
Search more.